A recent study of 6, 403 people showed that those treated with the drug pravastatin, one of the effects of which is to reduce cholesterol, had about one-third fewer nonfatal heart attacks and one-third fewer deaths from coronary disease than did those not taking the drug. This result is consistent with other studies, which show that those who have heart disease often have higher than average cholesterol levels. This shows that lowering cholesterol levels reduces the risk of heart disease. The argument's reasoning is flawed because the argument ['fails to consider that pravastatin may reduce the risk of heart disease but not as a consequence of its lowering cholesterol levels', 'relies on past findings, rather than drawing its principal conclusion from the data found in the specific study cited', 'neglects the possibility that pravastatin may have severe side effects', 'draws a conclusion regarding the effects of lowering cholesterol levels on heart disease, when in fact the conclusion should focus on the relation between pravastatin and cholesterol levels']